The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Folate receptor alpha (FRa; FOLR1) expression and persistence in ovarian cancer in clinical trial samples and real-world patient cohort.
 
Elizabeth Swisher
Leadership - IDEAYA Biosciences
Stock and Other Ownership Interests - IDEAYA Biosciences
Research Funding - GlaxoSmithKline
 
Qu Zhang
Employment - Abbvie
Stock and Other Ownership Interests - Abbvie
 
Manal Mehibel
Employment - Abbvie
Stock and Other Ownership Interests - Abbvie
 
David Masica
Employment - Abbvie
Stock and Other Ownership Interests - Abbvie
 
Sribalaji Lakshmikanthan
Employment - Abbvie
Stock and Other Ownership Interests - Abbvie
 
Emily Deutschman
Employment - Abbvie
Stock and Other Ownership Interests - Abbvie
 
Peter Ansell
Employment - Abbvie
Stock and Other Ownership Interests - Abbvie
 
Robert Coleman
Employment - US Oncology; Vaniam Group
Stock and Other Ownership Interests - McKesson/US Oncology Network
Consulting or Advisory Role - Abbvie; Alkermes; Alkermes; AstraZeneca/MedImmune; Clovis Oncology; Eisai; Genentech/Roche; Genmab; GlaxoSmithKline; GOG Foundation; Gradalis; Immunogen; Karyopharm Therapeutics; Merck; Merck
Research Funding - Alkermes; AstraZeneca/MedImmune; Immunogen (Inst); Karyopharm Therapeutics (Inst); Lilly (Inst); Merck; Pfizer (Inst); Regeneron (Inst)
Travel, Accommodations, Expenses - Array BioPharma; AstraZeneca/MedImmune; Clovis Oncology; Clovis Oncology; GOG Foundation; Merck; Research to Practice; Roche/Genentech; Sotio; Vaniam Group